Blockade of TGF-β Signaling With Novel Synthetic Antibodies Limits Immune Exclusion and Improves Chemotherapy Response in Metastatic Ovarian Cancer Models

OncoImmunology - United States
doi 10.1080/2162402x.2018.1539613
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Continuous Docetaxel Chemotherapy Improves Therapeutic Efficacy in Murine Models of Ovarian Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2010English

Serological Markers Associated With Response to Immune Checkpoint Blockade in Metastatic Gastrointestinal Tract Cancer

JAMA network open
Medicine
2019English

Protection From Obesity and Diabetes by Blockade of TGF-β/Smad3 Signaling

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2011English

TGF-β Family Signaling in Tumor Suppression and Cancer Progression

Cold Spring Harbor perspectives in biology
BiochemistryGeneticsMolecular Biology
2017English

TGF-β Signaling

WormBook
2005English

DHEA-induced Ovarian Hyperfibrosis Is Mediated by TGF-β Signaling Pathway

Journal of Ovarian Research
GynecologyOncologyObstetrics
2018English

Enhancing Chemotherapy Response With Bmi-1 Silencing in Ovarian Cancer

PLoS ONE
Multidisciplinary
2011English

Intracellular and Extracellular TGF-β Signaling in Cancer: Some Recent Topics

Frontiers of Medicine
Medicine
2018English

Correction: Ruxolitinib Sensitizes Ovarian Cancer to Reduced Dose Taxol, Limits Tumor Growth and Improves Survival in Immune Competent Mice

Oncotarget
Oncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy